How We WorkOrder NowSupport Privacy

Movers To Watch – Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

on 20/04/2013

Houston, TX – April 20, 2013 — (Net PR News) – AnotherWinningTrade.com delivers quality trading ideas for the elite investor that has the financial wherewithal and market nimbleness to profit on small moves in a stock’s price. Become a member and you will be provided with real-time alerts intended to provide you with the opportunity to make profitable trades. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Stocks that are being watched this morning are: Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

Shares of Catalyst Pharmaceutical Partners (NASDAQ:CPRX) closed higher in the last trading session after an analyst at Aegis upgraded Catalyst Pharmaceutical shares to a “buy” rating in a research note issued to investors on 18th April. The firm currently has a price target of $2.50 on the stock.

Will CPRX Get Buyers Even After The Recent Gain? Find Out Here

Zacks analysts also upgraded Catalyst Pharmaceutical (CPRX) shares to an “outperform” rating from “neutral” rating with a price target of $0.60 in a research note written to investors 11th April.

Earlier this month, the company announced its financial results for the year ended December 31, 2012. The company posted a net loss of $4,076,386, or $0.14 per share, for the year ended December 31, 2012, versus 6,391,062, or $0.29 per share, in the previous year.

Anacor Pharmaceuticals Inc (NASDAQ:ANAC) shares jumped 13.60 percent in the last trading session on Friday. The biopharmaceutical company recently stated that the Bill & Melinda Gates Foundation will give $17.7 million to Anacor Pharmaceuticals to support its development of drugs for two filarial worm diseases and tuberculosis.

What was the Moving Force behind ANAC’s Bullish Run? Read This Research Report on ANAC

According to the research deal, the Gates Foundation will also make an investment of as much as $5 billion in Anacor Pharmaceuticals (ANAC) stock. In the last trading session, Anacor shares, after opening at $7.07, touched a high price of $8.25, and finally closed at $8.02 after gaining 0.96.

Disclaimer:

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Source: anotherwinningtrade Posted Sat, April 20, 2013 11:44 - Permalink